Key result
Presence of Coxsackievirus B1 antibodies was associated with an increased risk of newly diagnosed type 1 diabetes in children (OR 1.7; 95% CI 1.0-2.9).
Why the study?
Is the presence of Coxsackievirus B1 antibodies associated with an increased risk of newly diagnosed type 1 diabetes in children?
Case-Control (n=498)
Yes
Is the presence of Coxsackievirus B1 antibodies associated with an increased risk of newly diagnosed type 1 diabetes in children?
Odds Ratio: 1.7 (95% CI 1–2.9)
The study suggests an association between Coxsackievirus B1 and type 1 diabetes, highlighting its possible role as a diabetogenic virus.
No takes yet. Share an insight, caveat, or question.
Suggests enteroviral triggers in pediatric type 1 diabetes; hypothesis-generating and requires prospective confirmation before clinical application.
Oikarinen et al. (2013) conducted a case-control in Type 1 diabetes (n=498). Coxsackievirus B1 (CVB1) antibodies vs. Matched control children was evaluated on Type 1 diabetes (OR 1.7, 95% CI 1.0-2.9). Presence of Coxsackievirus B1 antibodies was associated with an increased risk of newly diagnosed type 1 diabetes in children (OR 1.7; 95% CI 1.0-2.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: